{"article":{"__typename":"BlogArticle","id":"BlogArticle:252541","categories":[{"slug":"body","__typename":"Category"}],"content":[{"__typename":"ArticleParagraphContent","subtype":null,"idAttr":"","innerHtml":"Bill Doyle of Novocure, a company that developed non-invasive technology to control cell division in glioblastoma tumors, spoke at TEDMED 2012 about the role low-intensity alternating electric fields can have on cancer therapy:"},{"__typename":"ArticleLegacyHtml","tagName":"P","idAttr":"","className":"","style":"","innerHtml":"

"},{"__typename":"ArticleLegacyHtml","tagName":"HR","idAttr":"","className":"","style":"","innerHtml":""},{"__typename":"ArticleParagraphContent","subtype":null,"idAttr":"","innerHtml":"This post also appears on medGadget, an Atlantic partner site."}],"editorialProject":null,"primaryCategory":{"__typename":"Channel","displayName":"Health","url":"https://www.theatlantic.com/health/","slug":"health"},"reviews":[],"embeds":[{"type":"iframe","src":"https://www.youtube.com/embed/rt5sa93gWSQ?wmode=transparent","__typename":"Embed"}],"authors":[{"id":"Author:3434","displayName":"medGadget","url":"https://www.theatlantic.com/author/medgadget/","biography":{"default":"medGadget is written by a group of MDs and biomedical engineers.","__typename":"Biography"},"socialMedia":[],"__typename":"Author","slug":"medgadget"}],"preview":null,"layout":"standard","secondaryByline":"","dek":"","url":"https://www.theatlantic.com/health/archive/2012/02/using-low-intensity-electric-fields-as-a-form-of-cancer-therapy/252541/","title":"Using Low-Intensity Electric Fields as a Form of Cancer Therapy","seoTitle":"Using Low-Intensity Electric Fields as a Form of Cancer Therapy","dateModified":"2012-04-04T20:17:47Z","datePublished":"2012-02-10T21:03:53Z","hasMeter":true,"primaryChannel":{"displayName":"Health","__typename":"Channel","slug":"health"},"shareImage1x1":null,"shareImage16x9":null,"shareImage4x3":null,"shareImageDefault":null,"shareImageSquareDefault":null,"shareImageLeadArt":null,"shareDek":"Bill Doyle of Novocure, a company that has developed non-invasive technology to control cell division in glioblastoma tumors, speaks.","shareText":null,"shareTitle":"Using Low-Intensity Electric Fields as a Form of Cancer Therapy","editorsNote":null,"leadArt":null,"narratedAudio":null,"narratedAudioImage":null,"fbiaUrl":"https://www.theatlantic.com/facebook-instant/article/252541/","canonicalUrl":"https://www.theatlantic.com/health/archive/2012/02/using-low-intensity-electric-fields-as-a-form-of-cancer-therapy/252541/","syndication":"ALL","shareImage2x1":null,"shareImageSmall":null,"channels":[{"slug":"health","__typename":"Channel"}],"watsonInfo":{"keywords":["Atlantic partner site","glioblastoma tumors","non-invasive technology","cell division","electric fields","cancer therapy","low-intensity","Doyle"],"__typename":"WatsonInfo"},"slug":"using-low-intensity-electric-fields-as-a-form-of-cancer-therapy","grapeshot":{"segments":["gv_safe","gb_safe","pos_bofa-kwlist","pos_lexus_fy23","pos_safe_core","pos_safe_strict","gs_health","gs_health_specialities","gs_health_cancer"],"__typename":"Grapeshot"},"advertisingInfo":{"disableHouseAd":false,"__typename":"AdvertisingInfo"}}}

Sections

The Print Edition